D-glucose ( DrugBank: D-glucose, Glucose )

3 diseases

49. 全身性エリテマトーデス

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00029926 (ClinicalTrials.gov)	January 2002	26/1/2002	Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity	A Pilot Study of F-18FDG Positron Emission Tomography (PET) to Assess the Distribution of Activated ...	Lupus Erythematosus;Systemic	Drug: 2-deoxy-2 [F-18] fluoro-2-d-glucose	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	NULL	Completed	N/A	N/A	Both	20	N/A	United States

臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01953965 (ClinicalTrials.gov)	September 2013	26/9/2013	Look at Way the Heart Functions in People With Pulmonary Hypertension (PH) Who Have Near Normal Righ ...	11C-acetate/18Fluorodeoxyglucose-FDG PET/Cardiac MRI in Pulmonary Hypertension	Pulmonary Arterial Hypertension;Chronic Thromboembolic Pulmonary Hypertension	Drug: 11C-acetate;Drug: [18F]Fluoro-2-deoxy-2-D-glucose;Drug: MultiHance	Brigham and Women's Hospital	University of Pennsylvania;University of Maryland;Yale University	Terminated	18 Years	72 Years	Both	4	Phase 2	United States

臨床試験数 : 157 / 薬物数 : 107 - (DrugBank : 22) / 標的遺伝子数 : 14 - 標的パスウェイ数 : 54

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01953965 (ClinicalTrials.gov)	September 2013	26/9/2013	Look at Way the Heart Functions in People With Pulmonary Hypertension (PH) Who Have Near Normal Righ ...	11C-acetate/18Fluorodeoxyglucose-FDG PET/Cardiac MRI in Pulmonary Hypertension	Pulmonary Arterial Hypertension;Chronic Thromboembolic Pulmonary Hypertension	Drug: 11C-acetate;Drug: [18F]Fluoro-2-deoxy-2-D-glucose;Drug: MultiHance	Brigham and Women's Hospital	University of Pennsylvania;University of Maryland;Yale University	Terminated	18 Years	72 Years	Both	4	Phase 2	United States